Anıl Can ERGÜN

Anıl Can ERGÜN

Auto-generated profile, based on publicly available information

Anıl Can ERGÜN


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in The Turkish Journal of Geriatrics
Verified
Journal Article
Open access
PDF file
HKHabibe Kafes
Habibe Kafes
BTBahar TEKIN TAK
Bahar TEKIN TAK
AEAnıl Can ERGÜN
Anıl Can ERGÜN
ÖKÖzge Çakmak Karaaslan
Özge Çakmak Karaaslan
ATAhmet Temi̇zHan
Ahmet Temi̇zHan
FEfirdevs aysenur ekizler
firdevs aysenur ekizler
Introduction: The objective of this investigation was to determine whether the systemic immune-inflammation index (SII) and pan-immune-inflammation value (PIV), which serve as comprehensive indicators of systemic inflammatory pathways, possess the prognostic capacity to identify future stent thrombosis (ST) in geriatric STEMI patients. Materials and Method: We comprehensively screened a consecutive cohort of 1,683 elderly individuals (aged 75.3 ± 6.8 years; 64.6% male) who had been treated with primary percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infarction (STEMI). Stratification was performed based on the clinical manifestation of angiographically confirmed ST during follow-up. Both SII and PIV scores were computed from standard complete blood counts obtained at the time of initial clinical presentation. Results: Over an average follow-up duration of 30 ± 10 months, definite ST was documented in 104 individuals (6.2%). Patients experiencing ST exhibited distinct baseline profiles, characterized by a higher prevalence of tobacco use and hypertension, a greater frequency of early dual antiplatelet therapy (DAPT) cessation (<30 days), prolonged total stent lengths, and markedly elevated baseline high-sensitivity C-reactive protein (hs-CRP), SII, and PIV levels. In multivariable Cox proportional hazards modeling, both admission PIV and SII emerged as robust, standalone indicators of subsequent ST. Furthermore, correlation analyses demonstrated that hs-CRP levels fluctuated in tandem with both SII (r=0.342, p<0.001) and PIV (r=0.268, p<0.001) values. Conclusion: In summary, these data demonstrate that baseline immunoinflammatory indices serve as independent and highly reliable indicators of subsequent ST development within the high-risk geriatric cohort treated with primary PCI for STEMI. Keywords: Aged; Biomarkers; Inflammation; Stent; Thrombosis; ST Elevation Myocardial Infarction.